dipyridamole has been researched along with Mumps in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Mumps: An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujieda, M | 1 |
Kinoshita, A | 1 |
Naruse, K | 1 |
Nakayama, T | 1 |
Moriki, T | 1 |
Wakiguchi, H | 1 |
Kurashige, T | 1 |
1 other study available for dipyridamole and Mumps
Article | Year |
---|---|
Mumps associated with immunoglobulin A nephropathy.
Topics: Antibodies, Viral; Biopsy; Child, Preschool; Dipyridamole; Enzyme-Linked Immunosorbent Assay; Glomer | 2000 |